University of Ioannina
Συγκριτική μελέτη της επίδρασης της χορήγησης αμιωδαρόνης και δρονεδαρόνης στις κακοήθεις κοιλιακές αρρυθμίες μετά από έμφραγμα του μυοκαρδίου: πειραματική μελέτη
Abstract
dc:descriptionAmiodarone is one of the most effective antiarrhythmic compounds currently available for the treatment of life- threatening arrhythmias. Chronic treatment with amiodarone is associated with a slow onset of action, thus large loading doses are required before clinical efficacy can be established. In clinical practice, the role of amiodarone is entrenched, but its side-effect profile during chronic ministration remains of concern. The development of thyrotoxicity has been attributed to the iodinated nature of the molecule. Dronedarone, a structurally related non-iodinated benzofuran-derivative of amiodarone, was developed to overcome these toxic effects. However, the issue of amiodarone-induced thyrotoxicity is not fully understood, as an additional iodine independent mechanism has been suggested. The efficacy of dronedarone in the treatment of ventricular arrhythmias during acute myocardial infarction is not well established. Previous studies in anaesthetised animals indicated that dronedarone and amiodarone have comparable antiarrhythmic properties. Firstly, we investigated the effects of chronic treatment with amiodarone or dronedarone on thyroid function and on ventricular tachyarrhythmias during acute coronary ligation in rats. Secondly, we assessed the safety and efficacy of a single, large, oral amiodarone dosing regimen, administered immediately after Ml generation. For the needs of our first experiment, fifty-five Wistar rats were randomly allocated to a 2-week oral treatment with either vehicle (n=18), amiodarone (30 mg/kg, n=20), or dronedarone (30 mg/kg, n=17). The protocol of the second study was quite different. Forty six rats were randomly allocated into two oral amiodarone treatment arms: (a) chronic (30 mg/kg daily for 2 weeks, or vehicle) and (b) single dose (100 mg/kg, or vehicle). In the acute amiodarone treatment arm, the drug was administered five minutes after myocardial ischemia induction. Myocardial infarction was generated by left coronary artery ligation. The electrocardiogram was recorded for 24 hours, using an implanted telemetry transmitter. Episodes of ventricular tachycardia/fibrillation, mortality rates and catecholamine levels were analyzed for both studies. In the first study, monophasic action potential recordings were obtained from the left ventricular epicardium at baseline and 24 h post-myocardial infarction and thyroid hormone levels were measured. Infarct size was measured at the end of the experimental procedure in any case. Thyroid function was similar in the 3 groups in the first part of the study. Compared to controls, chronic treatment with amiodarone and dronedarone equally decreased the number of ventricular tachycardia/fibrillation episodes by approximately 75%. Both agents prevented the increase in monophasic action potential duration and in beat-to-beat variation. Norepinephrine levels were lower only after amiodarone treatment. Despite the observed antiarrhythmic effect, total mortality did not differ between groups (38.8% in controls, 30.0% in the amiodarone group and 58.8% in the dronedarone group), because of excess bradyarrhythmic mortality in both drug groups that reached significance in the dronedarone group. As far as the second part of the study is concerned, no differences in infarct size were found between groups. Compared to controls (22.7±10.9), there was a similar reduction in the number of tachyarrhythmia episodes after either chronic (2.6±1.6, p=0.0011), or acute (3.6±1.7, p=0.031) amiodarone administration. Norepinephrine levels were lower only after chronic treatment. Total mortality did not differ between groups, because of excess bradyarrhythmic mortality mainly in the chronic amiodarone group. Chronic treatment with dronedarone and amiodarone display similar antiarrhythmic efficacy post-myocardial infarction, partly by preventing repolarization inhomogeneity. However, dronedarone increases bradyarrhythmic mortality possibly secondary to its negative inotropic effects. Amiodarone did not have the same effect, but it did not manage to improve survival at the end. On the contrary, acute oral amiodarone administration at large doses in the rat was associated with rapid antiarrhythmic effect and probably with less mortality rates.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agelaki, Maria
- Αγγελάκη, Μαρία
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20073